Literature DB >> 15294947

TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response.

Nalân Utku1, Anke Boerner, Antje Tomschegg, Fatima Bennai-Sanfourche, Grit-Carsta Bulwin, Thomas Heinemann, Jürgen Loehler, Richard S Blumberg, Hans-Dieter Volk.   

Abstract

The membrane protein T cell immune response cDNA 7 (TIRC7) was recently identified and was shown to play an important role in T cell activation. To characterize the function of TIRC7 in more detail, we generated TIRC7-deficient mice by gene targeting. We observed disturbed T and B cell function both in vitro and in vivo in TIRC7(-/-) mice. Histologically, primary and secondary lymphoid organs showed a mixture of hypo-, hyper-, and dysplastic changes of multiple lymphohemopoietic compartments. T cells from TIRC7(-/-) mice exhibited significantly increased proliferation and expression of IL-2, IFN-gamma, and IL-4 in response to different stimuli. Resting T cells from TIRC7(-/-) mice exhibited decreased CD62L, but increased CD11a and CD44 expression, suggesting an in vivo expansion of memory/effector T cells. Remarkably, activated T cells from TIRC7(-/-) mice expressed lower levels of CTLA-4 in comparison with wild-type cells. B cells from TIRC7-deficient mice exhibited significantly higher in vitro proliferation following stimulation with anti-CD40 Ab or LPS plus IL-4. B cell hyperreactivity was reflected in vivo by elevated serum levels of various Ig classes and higher CD86 expression on B cells. Furthermore, TIRC7 deficiency resulted in an augmented delayed-type hypersensitivity response that was also reflected in increased mononuclear infiltration in the skin obtained from TIRC7-deficient mice food pads. In summary, the data strongly support an important role for TIRC7 in regulating both T and B cell responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294947     DOI: 10.4049/jimmunol.173.4.2342

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  RNA interference-mediated silencing of Atp6i prevents both periapical bone erosion and inflammation in the mouse model of endodontic disease.

Authors:  Junqing Ma; Wei Chen; Lijie Zhang; Byron Tucker; Guochun Zhu; Hajime Sasaki; Liang Hao; Lin Wang; Hongliang Ci; Hongbing Jiang; Philip Stashenko; Yi-Ping Li
Journal:  Infect Immun       Date:  2013-04       Impact factor: 3.441

2.  FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

Authors:  F Sellebjerg; M Krakauer; M Khademi; T Olsson; P S Sørensen
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

3.  Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice.

Authors:  N Utku; T Heinemann; M Winter; C G Bulwin; M Schlawinsky; P Fraser; E E S Nieuwenhuis; H-D Volk; R S Blumberg
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

4.  Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis.

Authors:  Christopher J Edwards; Jeffrey L Feldman; Jonathan Beech; Kathleen M Shields; Jennifer A Stover; William L Trepicchio; Glenn Larsen; Brian Mj Foxwell; Fionula M Brennan; Marc Feldmann; Debra D Pittman
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

5.  Prediction of graft-versus-host disease in humans by donor gene-expression profiling.

Authors:  Chantal Baron; Roland Somogyi; Larry D Greller; Vincent Rineau; Peter Wilkinson; Carolyn R Cho; Mark J Cameron; David J Kelvin; Pierre Chagnon; Denis-Claude Roy; Lambert Busque; Rafick-Pierre Sékaly; Claude Perreault
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

6.  Identification of contributing genes of Huntington's disease by machine learning.

Authors:  Jack Cheng; Hsin-Ping Liu; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  BMC Med Genomics       Date:  2020-11-23       Impact factor: 3.063

Review 7.  Immunomodulation in the Treatment of Periodontitis: Progress and Perspectives.

Authors:  Bo Yang; Xuefei Pang; Zhipeng Li; Zhuofan Chen; Yan Wang
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

Review 8.  CTLA-4 trafficking and surface expression.

Authors:  Elke Valk; Christopher E Rudd; Helga Schneider
Journal:  Trends Immunol       Date:  2008-05-09       Impact factor: 16.687

9.  RNAi-mediated silencing of Atp6i and Atp6i haploinsufficiency prevents both bone loss and inflammation in a mouse model of periodontal disease.

Authors:  Hongbing Jiang; Wei Chen; Guochun Zhu; Lijie Zhang; Byron Tucker; Liang Hao; Shengmei Feng; Hongliang Ci; Junqing Ma; Lin Wang; Philip Stashenko; Yi-Ping Li
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma.

Authors:  Thomas Albrecht; Benjamin Goeppert; Fritz Brinkmann; Alphonse Charbel; Qiangnu Zhang; Johannes Schreck; Nina Wilhelm; Stephan Singer; Bruno C Köhler; Christoph Springfeld; Arianeb Mehrabi; Peter Schirmacher; Anja A Kühl; Monika N Vogel; Holger Jansen; Nalân Utku; Stephanie Roessler
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.